Evidence & regulatory context
- Mechanism
- Genetic overexpression strategy; no ChEMBL entity and no matching human trial.
- Target
- Not recorded
- Injury models
- Haemorrhage/shock
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseHaemorrhage/shockUnspecifiedC57BL/6 (transgenic)Antioxidant pretreatment before injury
Model: Trauma/injury-induced acute hepatic insulin resistance (critical illness diabetes)
Reducing mitochondrial ROS via SOD2 overexpression or antioxidants prevented acute hepatic insulin resistance and stress signalling after injury.
Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.
